Cytokine response and clinicopathological findings in Brucella infected camels (Camelus dromedarius)

Veterinarni Medicina

Volumn 54, Issue 1, 2009, Pages 25-32

  El Boshy, M ^a   Abbas, H ^b   El Khodery, Sabry ^a   Osman, S ^c  

^a Mansoura University   (Egypt)

^b ANIMAL HEALTH RESEARCH INSTITUTE   (Egypt)

^c Kafrelsheikh University   (Egypt)

Author keywords

Biochemical parameters; Brucellosis; Camel; Cytokines; Egypt; Hematology

Indexed keywords

ANIMALIA; BRUCELLA; BRUCELLA MELITENSIS; BRUCELLA MELITENSIS BIOVAR ABORTUS; CAMELIDAE; CAMELUS DROMEDARIUS;

EID: 67650179582     PISSN: 03758427     EISSN: None     Source Type: Journal    
DOI: 10.17221/3044-VETMED     Document Type: Article

References (57)

1. Abu Damir H., Tageldin M.H., Kenyon S.J. Idris O.F. (1989): Isolation of Brucella abortus from experimentally infected dromedary camels in Sudan: a preliminary report. Veterinary Research Communications, 13, 403-406
2. Adams L.G. (2002): The pathology of brucellosis reflects the outcome of the battle between the host genome and the Brucella genome. Veterinary Microbiology, 90, 553-561
3. Afzal M., Sakkir M. (1994): Survey of antibodies against various infectious disease agents in racing camels in Abu Dhabi, United Arab Emirates. Review Science and Technology, 13, 787-792
4. Akbulut, H., Celik, I., Akbulut A. (2007): Cytokine levels in patients with brucellosis and their relations with the treatment. Indian Journal of Medical Microbiology, 25, 387-390
5. Al-Majali A.M., Al-Qudah K.M., Al-Tarazi Y.H., Al-Rawashdeh O.F. (2008): Risk factors associated with camel brucellosis in Jordan. Tropical Animal Health and Production, 40, 193-200
6. Al-Shamahy H.A. (1999): Seropositivity for brucellosis in a sample of animals in the Republic of Yemen. Eastern Mediterranean Health Journal, 5, 1035-1041
7. Alton G.G., Jones L.M., Angus R.D., Verger J.M. (1988): Techniques for the Brucellosis Laboratory. INRA, Paris. 123-130
8. Baumann M.P., Zessin K.H. (1992): Productivity and health of camels (Camelus dromedarius) in Somalia: associations with trypanosomosis and brucellosis. Tropical Animal Health and Production, 24, 145-156
9. Braun U., Pospischil A., Pusterla N., Winder C. (1995): Ultrasonographic findings in cows with cholestasis. Veterinary Record, 18, 537-543
10. Budak F., Goral G., Heper Y., Yilmaz E., Aymak F., Basturk B., Tore O., Ener B., Oral H.B. (2007): IL-10 and IL-6 gene polymorphisms as potential host susceptibility factors in Brucellosis. Cytokine, 38, 32-36
11. Cooper C.W. (1991): The epidemiology of human brucellosis in a well defined urban population in Saudi Arabia. Journal of Tropical Medicine and Hygiene, 94, 416-422
12. Damir H.A., Kenyon S.J., Khalaf Alla A.E., Idris O.F. (1984): Brucella antibodies in Sudanese camels. Tropical Animal Health and Production, 16, 209-212
13. Dash P.K., Joshi H.C. (1989): Clinico-biochemical studies on acute toxic nephropathy in goats due to uranyl nitrate. Veterinary and Human Toxicology, 31, 5-9
14. Demirdag K., Ozden M., Kalkan A., Godekmerdan A., Sirri Kilic S. (2003): Serum cytokine levels in patients with acute brucellosis and their relation to the traditional inflammatory markers. FEMS Immunology Medical Microbiology, 28,149-153
15. Dinarello C.A. (1996): Biologic basis for interleukin-1 in disease. Blood, 87, 2095-2147
16. Dinarello C.A. (2005): Blocking IL-1 in systemic inflammation. Journal of Experimental Medicine, 2, 1355-1359
17. Dornand J., Gross A., Lafont V., Liautard J., Oliaro J., Liautard J.P. (2002): The innate immune response against Brucella in humans. Veterinary Microbiology, 20, 383-394
18. Dzata G.K., Confer A.W., Wyckoff J.H. (1991): The effects of adjuvant on immune responses in cattle injected with a Brucella abortus soluble antigen. Veterinary Microbiology, 29, 27-48
19. Enright F.M., Walker J.V., Jeffers G., Deyoe B.L. (1984): Cellular and humoral responses of Brucella abortusinfected bovine fetuses. American Journal of Veterinary Research, 45, 424-430
20. Erdogan S., Celik S., Aslantas O., Kontas T., Ocak S. (2007): Elevated cAMP levels reverse Brucella melitensis-induced lipid peroxidation and stimulate IL-10 transcription in rats. Research in Veterinary Science, 82, 181-186
21. Fernandes D.M., Baldwin C.L. (1995): Interleukin-10 downregulates protective immunity to Brucella abortus. Infection and Immunity, 63, 1130-1133
22. Fernandez-Lago L., Orduna A., Vizcaino N. (2005): Reduced interleukin-18 secretion in Brucella abortus 2308-infected murine peritoneal macrophages and in spleen cells obtained from B. abortus 2308-infected mice. Journal of Medical Microbiology, 54, 527-531
23. Gameel S.E.A.M., Mohammed S.O., Mustafa A.A., Azwai S.M. (1993): Prevalence of camel brucellosis in Libya. Tropical Animal Health and Production, 25, 91-93
24. Giambartolomei G.H., Delpino M.V., Cahanovich M.E., Wallach J.C., Baldi P.C., Velikovsky C.A., Fossati C.A. (2002): Diminished production of T helper 1 cytokines correlates with T cell unresponsiveness to Brucella cytoplasmic proteins in chronic human brucellosis. Journal of Infectious Diseases, 15, 252-259
25. Hamdy M.F., Amin A.S. (2002): Detection of Brucella species in the milk of infected cattle, sheep, goats and camels by PCR. Veterinary Journal, 163, 299-305
26. Hegazy A.A., El Dughaym A., Alaknah M., Housawi F.M.T., Hatem M.E. (2004): Studies on mastitis in female camel with special reference to brucellosis. Journal of Camel Science, 1, 96-102
27. Hoover D.L., Crawford R.M., Van De Verg L.L., Izadjoo M.J., Bhattacharjee A.K., Paranavitana C.M., Warren R.L., Nikolich M.P., Hadfield T.L. (1999): Protection of mice against brucellosis by vaccination with Brucella melitensis WR201 (16MDeltapurEK). Infection and Immunity, 67, 5877-5884
28. Kalaitzakis E., Roubies N., Panousis N., Pourliotis K., Kaldrymidou E., Karatzias H. (2007): Clinicopathologic evaluation of hepatic lipidosis in periparturient dairy cattle. Journal of Veterinary Internal Medicine, 21, 835-845
29. Kudi A.C., Kalla D.J.U., Kudi M.C., Kapio G.I. (1997): Brucellosis in camels. Journal of Arid Environments, 37, 413-417
30. Lee Y., Park B.C., Lee Do H., Bae K.H., Cho S., Le C.H., Lee J.S., Myung P.K., Park S.G. (2006): Mouse transthyretin-related protein is a hydrolase which degrades 5-hydroxyisourate, the end product of the uricase reaction. Molecular Cells, 31, 141-145
31. Mantur B.G., Amarnath S., Shinde R.S. (2007): Review of clinical and laboratory features of human Brucellosis. Indian Journal of Medical Microbiology, 25, 188-202
32. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. (2001): Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology, 19, 683-765
33. Murphy E.A., Sathiyaseelan J., Parent M.A., Zou B., Baldwin C.L. (2001): Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology, 103, 511-518
34. Musa M.T., Eisa M.Z., El Sanousi E.M., Abdel Wahab M.B., Perrett L. (2008): Brucellosis in Camels (Camelus dromedarius) in Darfur, Western Sudan. Journal of Comparative Pathology, 138, 151-155
35. Nicklin M.J., Hughes D.E., Barton J.L., Ure J.M., Duff G.W. (2000): Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. Journal of Experimental Medicine, 191, 303-312
36. Odbileg R., Konnai S., Ohashi K., Onuma M. (2005): Molecular cloning and phylogenetic analysis of inflammatory cytokines of Camelidae (llama and camel). Journal of Veterinary Medical Science, 67, 921-925
37. Odbileg R., Purevtseren B., Batsukh Z., Konnai S., Ohashi K., Onuma M. (2006): Complete cDNA sequences and phylogenetic analyses of the Th1 and Th2 cytokines of the bactrian camel (Camelus bactrianus). Journal of Veterinary Medical Science, 68, 941-946
38. Odbileg R., Purevtseren B., Gantsetseg D., Boldbaatar B., Buyannemekh T., Galmandakh Z., Erdenebaatar J., Konnai S., Onuma M., Ohashi K. (2008): Cytokine responses in camels (Camelus bactrianus) vaccinated with Brucella abortus strain 19 vaccine. Journal of Veterinary Medical Science, 70, 197-201
39. Omer M.K., Skjerve E., Holstad G., Woldehiwet Z., Macmillan A.P. (2000): Prevalence of antibodies to Brucella spp. in cattle, sheep, goats, horses and camels in the State of Eritrea; influence of husbandry systems. Epidemiology and Infection, 125, 447-453
40. Palmer M.V., Cheville N.F., Tatum F.M. (1996): Morphometric and histopathologic analysis of lymphoid depletion in murine spleens following infection with Brucella abortus strains 2308 or RB51 or an htrA deletion mutant. Veterinary Pathology, 33, 282-289
41. Pasquali P., Adone R., Gasbarre L.C., Pistoia C., Ciuchini F. (2001): Mouse cytokine profiles associated with Brucella abortus RB51 vaccination or B. abortus 2308 infection. Infection and Immunity, 69, 6541-6544
42. Radostits O.M., Gay C.C., Hinchcliff K.W., Constable P.D. (2007): Veterinary Medicine. 10th ed. Elsevier Saunders, London. 389-390
43. Radwan A.I., Bekairi S.I., Mukayel A.A., Al-Bokmy A.M., Prasad P.V., Azar F.N., Coloyan E.R. (1995): Control of Brucella melitensis infection in a large camel herd in Saudi Arabia using antibiotherapy and vaccination with Rev. 1 vaccine. Review of Science and Technology, 14, 719-732
44. Sarafidis K., Diamanti E., Agakidis Ch., Karantaglis N., Roilidies E. (2006): Congenital brucellosis: a case report and review. In: 1st International Meeting on the Treatment of Human Brucellosis, Ioannina, Greece, 7-10
45. Saunders B.M., Liu Z., Zhan Y., Cheers C. (1993): Interleukin-6 production during chronic experimental infection. Immunolgy and Cell Biology, 71, 275-280
46. Saunders B.M., Frank A.A., Orme I.M., Cooper A.M. (2000): Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infection and Immunity, 68, 3322-3326
47. Schelling E., Diguimbaye C., Daoud S., Nicolet J., Zinsstag J. (2004): Seroprevalences of zoonotic diseases in nomads and their livestock in Chari-Baguirmi, Chad. Medicine Tropics, 64, 474-477
48. Seder R.A., Hill A.V. (2000): Vaccines against intracellular infections requiring cellular immunity. Nature, 17, 793-798
49. Stevens M.G., Olsen S.C. (1994): In vitro effects of live and killed Brucella abortus on bovine cytokine and prostaglandin E2 production. Veterinary Immunology and Immunopathollogy, 40, 149-161
50. Stevens M.G., Olsen S.C., Pugh G.W.J., Palmer M.V. (1994): Immune and pathologic responses in mice infected with Brucella abortus 19, RB51, or 2308. Infection and Immunity, 62, 3206-3212
51. Teshome H., Molla B., Tibbo M. (2003): A seroprevalence study of camel brucellosis in three camel-rearing regions of Ethiopia. Tropical Animal Health and Production, 35, 381-390
52. Trinchieri G. (2007): Interleukin-10 production by effector T cells: Th1 cells show self control. Journal of Experimental Medicine, 19, 239-243
53. World Health Organization (WHO) (1986): 6th Report of the Joint FAO/WHO Expert Committee on Brucellosis. WHO Technical Reports Series, 740. WHO, Geneva
54. Wyckoff J.H. 3rd., Howland J.L., Scott C.M., Smith R.A., Confer A.W. (2005): Recombinant bovine interleukin 2 enhances immunity and protection induced by Brucella abortus vaccines in cattle. Veterinary Microbiology, 30, 77-87
55. Yagoub I.A., Mohamed A.A., Salim M.O. (1990): Serological survey of Brucella abortus antibody prevalence in the one-humped camel (Camelus dromedarius) from eastern Sudan. Revue D'elevage et de Medecine Veterinaire des Pays Tropicaux, 43, 167-171
56. Zhan Y., Cheers C. (1993): Endogenous gamma interferon mediates resistance to Brucella abortus infection. Infection and Immunity, 61, 4899-4901
57. Zhan Y., Liu Z., Cheers C. (1996): Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infection and Immunity, 64, 2782-2786